In this episode, we are featuring Jaguar Health (Nasdaq: JAGX), a commercial-stage pharmaceutical company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress.

This interview is moderated by Robert Blum, Managing Partner at Lytham Partners, and features Lisa Conte, CEO at Jaguar Health.